查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1987207

正壓通氣（氣道正壓）呼吸器市場規模、佔有率、趨勢和預測：按產品類型、最終用戶和地區分類，2026-2034年

Positive Airway Pressure Devices Market Size, Share, Trends and Forecast by Product Type, End User, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 139 Pages | 商品交期: 2-3個工作天內

價格

2025年全球正壓通氣（PAP）呼吸器市場規模為40億美元。展望未來，IMARC Group預測，該市場將在2026年至2034年間以4.93%的複合年成長率成長，到2034年達到62億美元。目前，北美市場主導地位，預計2025年將佔35%的市場。該地區受益於許多因素，例如先進的醫療基礎設施、完善的正壓呼吸裝置保險報銷體系、較高的臨床認知度以及患者對PAP治療的強勁需求，所有這些因素都促進了PAP市場佔有率的成長。

推動這一市場發展的因素包括流行病學、技術和政策等多方面因素。阻塞型睡眠呼吸中止症（OSA）在全球範圍內的盛行率不斷上升，這主要歸因於肥胖症的增加、久坐的生活方式以及人口老齡化，從而擴大了持續氣道正壓通氣（PAP）治療的患者群體。此外，人們越來越意識到未經治療的睡眠呼吸中止症會導致高血壓、糖尿病和憂鬱症嚴重的健康後果，這促使人們尋求早期治療。政府優惠的報銷政策降低了經濟門檻，促進了有效設備的普及。此外，新興經濟體醫療保健支出的成長也逐漸擴大了PAP設備的覆蓋範圍，從而擴大了全球患者群體，並推動了PAP設備市場的成長。

美國之所以成為持續性正壓呼吸器（PAP）設備市場的領先地區，原因有很多。美國擁有完善的醫療保健體系，PAP治療的保險覆蓋範圍廣，睡眠診斷設施先進，且醫療專業人員對睡眠障礙的認知度很高。此外，醫療設備研發的大量投入也促使新一代PAP設備迅速推向市場。推動正壓呼吸裝置廣泛應用的重要因素之一是肥胖相關睡眠呼吸中止症病例的不斷增加。一項發表於2025年《瑞思邁》（ResMed）雜誌的研究估計，屆時美國將有約7,700萬成年人患有此病，較2020年成長約35%，30至69歲成年人中約有46%受到影響。此外，遠端醫療與PAP設備的結合，也有助於更好地監測治療過程，並提高患者對治療方案的依從性。

正壓通氣（PAP）設備市場趨勢：

人們越來越意識到睡眠呼吸中止症的嚴重後果

阻塞型睡眠呼吸中止症（OSA）在全球日益普遍，是推動PAP治療需求成長的最重要因素之一。 OSA的特徵是睡眠期間反覆出現呼吸暫停，與肥胖、老齡化以及久坐不動的生活方式和飲酒等因素密切相關。隨著越來越多的醫療專業人員和公共衛生組織投入大規模篩檢計畫和宣傳宣傳活動，越來越多的人被診斷出患有OSA，因此，接受PAP治療的患者也越來越多。世界各國政府都將睡眠健康列為優先事項，保險公司也正在擴大承保範圍，將PAP治療及相關設備納入其中。隨著人們越來越認知到未確診和未治療的OSA與高血壓、中風、心臟衰竭和2型糖尿病等慢性疾病之間的關聯，對OSA的診斷和治療需求也變得更加迫切。 2025 年，SleepRes 公司宣布其「Kricket PAP 系統」已獲得 FDA 510(k) 批准，該系統採用 Kairos 正壓通氣 (KPAP) 療法治療體重 66 磅（約 30 公斤）或以上的阻塞型睡眠呼吸中止症症 (OSA) 患者。

對家用PAP治療的需求日益成長

居家醫療管理模式轉移正在從根本上革新正壓通氣（PAP）治療市場及其終端使用者。不斷上漲的醫療成本、醫院感染風險以及對以患者為中心的護理日益成長的需求，都促使越來越多的患者選擇在家中舒適地進行睡眠呼吸中止症的自我管理治療。現代家用PAP設備便攜易用，配備低噪音馬達和直覺的介面，專為患者獨立使用而設計。居家睡眠監測服務的日益普及也簡化了治療流程，使患者能夠在睡眠檢查室之外快速開始PAP治療。醫療保健專業人員擴大利用PAP設備上的遠距遠端醫療平台來追蹤治療依從性並遠端調節壓力，從而最大限度地減少後續復診的需求。 2025年，Happy Health的「Happy Ring」獲得了FDA核准用於家庭睡眠監測。即使與多導睡眠圖這一黃金標準相比，它也擁有極高的準確性，這表明在這個快速變化的行業中，診斷技術與居家照護正在迅速融合。

提昇設備性能的技術進步

PAP（持續性呼吸道正壓通氣）技術的創新正在改變睡眠呼吸障礙的治療方式。持續性氣道正壓通氣（PAP）設備市場前景廣闊，這主要得益於市場對更安靜、更便攜且具備先進功能的設備的需求，例如自動壓力調節、加熱加濕器以及基於雲端的監測系統，這些系統使醫護人員能夠遠端追蹤患者的治療依從性。這些功能已被證實有助於提高患者的治療依從性，而這對於有效管理阻塞性睡眠呼吸中止症（OSA）至關重要。具備藍牙連接和行動應用程式功能的智慧型PAP設備的開發，使患者能夠追蹤治療資訊並獲得即時回饋，這也促進了治療的個人化。此外，利用人工智慧（AI）演算法根據患者的呼吸模式即時調節壓力水平的應用也日益普及。 2026年，專注於居家照護尖端產品的領先醫療技術公司Inogen, Inc.宣布推出Aurora CPAP面罩，為其不斷擴展的產品線再添新成員。 Aurora 的推出標誌著 Inogen 在加強其呼吸護理產品組合、為阻塞型睡眠呼吸中止症(OSA) 患者提供高品質、有效的面罩的策略上邁出了重要一步。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 二手資訊
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 調查方法

第3章執行摘要

第4章：引言

第5章：全球正壓通氣（氣道正壓通氣）呼吸器市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品類型分類

  • 自動正壓通氣（APAP）裝置
  • 持續性陽壓呼吸器（CPAP）裝置
  • 雙級正壓通氣（BiPAP）裝置

第7章 市場區隔：依最終用戶分類

  • 醫院和睡眠測試機構
  • 居家照護
  • 其他

第8章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第9章 SWOT 分析

第10章：價值鏈分析

第11章：波特五力分析

第12章：價格分析

第13章 競爭格局

  • 市場結構
  • 主要企業
  • 主要企業簡介
    • 3B Medical Inc.
    • Apex Medical Corp.
    • Compumedics Limited（D & DJ Burton Holdings Pty Ltd.）
    • Drive Devilbiss Healthcare（Drive International LLC）
    • Fisher & Paykel Healthcare Limited
    • Koninklijke Philips NV
    • Resmed Inc.
    • Smiths Group Plc
    • Somnetics International Inc.
    • Vyaire Medical Inc.
Product Code: SR112026A3679

The global positive airway pressure devices market size was valued at USD 4.0 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 6.2 Billion by 2034, exhibiting a CAGR of 4.93% from 2026-2034. North America currently dominates the market, holding a market share of 35% in 2025. The region benefits from advanced healthcare infrastructure, well-established reimbursement policies for sleep disorder treatments, high clinical awareness, and strong patient demand for PAP therapy, all collectively contributing to the positive airway pressure devices market share.

The market is driven by a combination of epidemiological, technological, and policy related factors. The increasing global occurrence of obstructive sleep apnea (OSA) driven by the heightened incidence of obesity, sedentary lifestyle habits, and aging populations, is creating a large pool of patient base for positive airway pressure (PAP) therapy. Apart from this, the increasing awareness about the severe health consequences of untreated sleep apnea, like hypertension, diabetes, and depression, is encouraging people to seek timely treatment. Favorable reimbursement policies by the government are lowering economic barriers and facilitating the adoption of effective devices. In addition, the increasing healthcare expenditure in emerging countries is gradually rising access to PAP devices, thereby expanding the global patient base and supporting the positive airway pressure devices market growth.

The United States has become a prominent area in the positive airway pressure devices market because of numerous reasons. The country has an established healthcare system with extensive insurance coverage for PAP therapy, advanced sleep diagnostic facilities, and a high level of awareness among healthcare professionals about sleep disorders. The United States also has strong investments in medical device R&D, which has led to the quick introduction of next-generation PAP devices in the market. One of the most important factors that have contributed to the adoption of positive airway pressure devices is the rising number of obesity-related sleep apnea cases, as stated in a study published in Resmed in 2025, nearly 77 million U.S. adults, which shows a relative increase of almost 35% since 2020 and affects 46% of adults aged 30-69 years. The integration of telehealth with PAP devices has also helped in monitoring therapy sessions and improving patient compliance with treatment regimens in the United States.

POSITIVE AIRWAY PRESSURE DEVICES MARKET TRENDS:

Heightened Awareness about Consequences of Sleep Apnea

The growing international incidence of obstructive sleep apnea represents one of the most influential drivers of demand for PAP therapy. OSA, which is defined by recurrent episodes of breathing cessation during sleep, has been closely linked to obesity, advancing age, and lifestyle factors such as a sedentary lifestyle and alcohol use. As greater numbers of healthcare providers and public health agencies invest in large-scale screening programs and education campaigns, more patients are being diagnosed with OSA and subsequently treated with PAP therapy. Governments in various international regions have placed a high priority on sleep health initiatives, with insurance companies expanding their coverage to include PAP therapy and accessories. The growing recognition of the link between undiagnosed and untreated OSA and chronic diseases such as hypertension, stroke, heart failure, and type 2 diabetes is further fueling the need for diagnosis and treatment. In 2025, SleepRes, Inc. announced that it has received FDA 510(k) clearance for its Kricket PAP system, which employs Kairos Positive Airway Pressure (KPAP) to treat obstructive sleep apnea in patients weighing more than 66 pounds.

Escalating Demand for Home-Based PAP Therapy

The paradigm shift towards home-based healthcare management is, at its core, revolutionizing the positive airway pressure devices market trends and end-users of positive airway pressure devices. Increasing healthcare expenditures, the risk of hospital-acquired infections, and the growing demand for patient-centric care have collectively encouraged more patients to take charge of their sleep apnea treatment in the comfort of their own homes. Contemporary home-use PAP devices are extremely portable, easy to use, and engineered with noise-reduced motors and intuitive interfaces that allow for independent use. The growing availability of home sleep testing services has also made the process more streamlined, allowing patients to quickly begin PAP therapy outside of the sleep lab. Healthcare professionals are increasingly using telemedicine platforms available on PAP devices to track therapy compliance and adjust pressures remotely, minimizing the need for follow-up consultations. In 2025, Happy Health's Happy Ring received FDA approval for home sleep testing, boasting high accuracy rates compared to the gold standard of polysomnography, illustrating the rapidly increasing integration of diagnostic technology and home-based care in this rapidly changing industry.

Technological Advancements Enhancing Device Performance

Innovation in PAP technology is changing the face of treatment for sleep-disordered breathing. The positive airway pressure devices market outlook is being influenced by the need for quieter, more portable devices with advanced features such as automatic pressure adjustment, heated humidifiers, and cloud-based monitoring systems that allow remote tracking of patient compliance by healthcare professionals. These features have been demonstrated to improve patient compliance, which has been a major factor in the effective management of OSA. The development of smart PAP devices with Bluetooth connectivity and mobile apps that enable patients to track therapy information and receive real-time feedback is also personalizing treatment. The use of artificial intelligence algorithms to adjust pressure levels in real-time according to the patient's breathing patterns is also becoming popular in the industry. In 2026, Inogen, Inc., a prominent medical technology firm focused on cutting-edge respiratory products for home care, revealed the introduction of Aurora CPAP masks, a new item in the growing Inogen lineup. Aurora's launch represents an important step in Inogen's strategy to enhance its respiratory care offerings and provide patients with quality, effective masks for obstructive sleep apnea (OSA).

POSITIVE AIRWAY PRESSURE DEVICES INDUSTRY SEGMENTATION:

Analysis by Product Type:

  • Automatic Positive Airway Pressure (APAP) Devices
  • Continuous Positive Airway Pressure (CPAP) Devices
  • Bi-level Positive Airway Pressure (BiPAP) Devices

Continuous positive airway pressure (CPAP) Devices holds 60% of the market share. CPAP devices are the most widely prescribed treatment for obstructive sleep apnea, delivering a continuous, steady stream of pressurized air through a mask to maintain airway patency during sleep. Their clinical effectiveness, cost-efficiency relative to advanced PAP systems, and simplicity of use have firmly established them as the gold standard for OSA management among healthcare providers and patients alike. Ongoing innovation in CPAP technology has further strengthened this dominance, with newer models featuring quieter motors, ergonomic mask designs, auto-adjusting pressure capabilities, and integrated digital health tools that enable remote patient monitoring and compliance tracking. The widespread availability of CPAP devices through home medical equipment providers and online channels has substantially improved accessibility across diverse markets. Strong reimbursement coverage for CPAP devices by government insurance programs in North America and Europe continues to support adoption.

Analysis by End User:

  • Hospitals and Sleep Labs
  • Home Care
  • Others

Hospitals and sleep labs lead the market with a share of 48%. These specialized clinical settings provide comprehensive diagnostic and therapeutic services for patients with sleep-disordered breathing, deploying advanced PAP devices as part of structured treatment protocols under medical supervision. Hospitals are equipped with state-of-the-art sleep laboratories capable of conducting full polysomnography studies, which enable clinicians to accurately titrate PAP pressure settings for individual patients. The presence of multidisciplinary care teams, including pulmonologists, neurologists, and respiratory therapists, ensures high-quality OSA management in hospital environments. Institutional procurement of PAP devices is supported by favorable reimbursement frameworks in key markets, particularly in North America and Europe. Additionally, the integration of hospital-based PAP programs with broader chronic disease management platforms for conditions such as cardiovascular disease and metabolic disorders supports coordinated patient care.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America, accounting for 35% of the share, enjoys the leading position in the market. The region's market leadership is underpinned by high sleep apnea prevalence, advanced healthcare infrastructure, and robust clinical adoption of PAP therapy. The United States has a well-established sleep medicine ecosystem featuring a large network of accredited sleep centers, experienced specialists, and strong insurance reimbursement policies that facilitate patient access to PAP devices. Canada also demonstrates consistent PAP device adoption, driven by government-funded healthcare services and increasing public awareness of sleep disorder management. Moreover, the region benefits from the concentration of leading PAP device manufacturers and an active regulatory environment that facilitates rapid approval and commercialization of innovative products. According to a study published in Respiratory Medicine in September 2025, an estimated 83.7 million adults, representing 32.4% of the United States adult population, had obstructive sleep apnea as of 2024, directly reflecting the robust and growing clinical demand for positive airway pressure devices market forecast-aligned therapeutic interventions across the region.

KEY REGIONAL TAKEAWAYS:

United States Positive Airway Pressure Devices Market Analysis

The United States positive airway pressure devices market is driven by its highly developed healthcare infrastructure, robust sleep medicine specialty ecosystem, and among the highest per-capita rates of sleep apnea diagnosis globally. The widespread availability of accredited sleep diagnostic centers, combined with comprehensive Medicare and private insurance coverage for PAP devices and accessories, significantly reduces the financial burden on patients and encourages timely treatment initiation. Increasing public health campaigns by professional organizations such as the American Academy of Sleep Medicine have substantially elevated awareness of OSA and its associated risks, including cardiovascular disease, stroke, and metabolic disorders. The integration of digital health technologies with PAP devices, including smartphone applications, cloud-based compliance monitoring, and remote patient management platforms, is further improving therapy adherence rates across the US population. Ongoing investment in R&D by domestic manufacturers ensures a steady pipeline of innovative PAP products entering the market. In February, Zydus Lifesciences revealed the introduction of PEPAIR, an Oscillating Positive Expiratory Pressure (OPEP) device aimed at aiding mucus clearance and enhancing breathing in individuals with chronic respiratory disorders, such as chronic obstructive pulmonary disease (COPD), asthma, and bronchiectasis.

Europe Positive Airway Pressure Devices Market Analysis

The European positive airway pressure devices market demonstrates consistent growth, supported by universal healthcare systems in major economies including Germany, France, the United Kingdom, Italy, and Spain that provide broad reimbursement coverage for sleep disorder diagnosis and PAP therapy. High awareness levels among healthcare professionals and expanding patient education initiatives have supported increased OSA diagnosis rates across the region. European regulatory bodies maintain rigorous standards for PAP device safety and efficacy, ensuring the availability of high-quality products across regional markets. The aging population in Western Europe, combined with rising obesity rates in younger demographics, continues to expand the pool of at-risk patients requiring PAP therapy. Strong investment in sleep medicine research and clinical trials across European academic institutions is generating evidence that supports guideline-driven PAP prescribing practices. In July 2024, the French government granted reimbursement approval for an innovative neurostimulation-based OSA therapy, reflecting Europe's strong policy commitment to expanding treatment options for sleep disorder patients and underscoring the region's progressive healthcare policy environment.

Asia-Pacific Positive Airway Pressure Devices Market Analysis

The Asia-Pacific positive airway pressure devices market is expanding rapidly, driven by increasing OSA diagnosis rates, growing healthcare expenditure, and improving medical infrastructure across major economies including China, Japan, India, South Korea, and Australia. Rising obesity rates and demographic aging across the region are significantly elevating the burden of sleep-disordered breathing, stimulating demand for PAP therapy. In Japan and South Korea, advanced healthcare infrastructure and strong insurance coverage are supporting high device adoption rates. In China and India, awareness campaigns and the expansion of sleep diagnostic centers are progressively closing the gap between OSA prevalence and diagnosis. As per a report by the Australian Institute of Health and Welfare published in November 2024, the Australian government invested USD 178.7 billion toward healthcare infrastructure development, significantly improving access to diagnostic and therapeutic services, including PAP devices, across the region.

Latin America Positive Airway Pressure Devices Market Analysis

The Latin America positive airway pressure devices market is at an emerging stage but exhibits significant growth potential, driven by increasing awareness of sleep apnea, expanding private healthcare networks, and a rising burden of obesity across the region. Countries including Brazil and Mexico are primary contributors to market activity, supported by improving access to sleep diagnostic services and government-led chronic disease management programs. According to the Pan American Health Organization (PAHO), obesity prevalence among adults in Latin America has increased substantially, with a major section of the adult population classified as obese across several major economies in 2024, directly elevating sleep apnea prevalence and fueling demand for PAP devices.

Middle East and Africa Positive Airway Pressure Devices Market Analysis

The Middle East and Africa positive airway pressure devices market is gradually developing, with significant growth potential concentrated in Gulf Cooperation Council (GCC) states including Saudi Arabia and the United Arab Emirates, where high obesity prevalence and rising healthcare investment are supporting market expansion. Africa's market remains nascent, constrained by limited healthcare infrastructure and low awareness. According to the World Health Organization (WHO), some GCC nations reported adult obesity rates increasing excessively, directly elevating the epidemiological burden of obstructive sleep apnea and increasing demand for PAP therapy. Government-backed healthcare modernization programs across the region are progressively expanding access to sleep diagnostic services and PAP treatment options.

COMPETITIVE LANDSCAPE:

The global positive airway pressure devices market is characterized by intense competition, with established multinational corporations and specialized medical device companies competing through continuous product innovation, regulatory approvals, and strategic collaborations. Leading players are focused on expanding their PAP device portfolios with advanced features including automated pressure adjustment, reduced noise levels, smart connectivity, and integrated cloud-based data platforms to differentiate their offerings and improve patient adherence. Strategic investments in research and development remain a priority as companies seek to address common barriers to long-term therapy compliance, including device discomfort and complexity. Partnerships with telehealth providers, insurance companies, and hospital networks are being pursued to enhance market reach and streamline patient access. While regulatory compliance and post-market surveillance requirements present ongoing operational complexities, leading manufacturers are investing in quality management systems and clinical evidence generation to support commercialization efforts across international markets and sustain their competitive positions.

The report provides a comprehensive analysis of the competitive landscape in the positive airway pressure devices market with detailed profiles of all major companies, including:

  • 3B Medical Inc.
  • Apex Medical Corp.
  • Compumedics Limited (D & DJ Burton Holdings Pty Ltd.)
  • Drive Devilbiss Healthcare (Drive International LLC)
  • Fisher & Paykel Healthcare Limited
  • Koninklijke Philips N.V.
  • Resmed Inc.
  • Smiths Group Plc
  • Somnetics International Inc.
  • Vyaire Medical Inc.

KEY QUESTIONS ANSWERED IN THIS REPORT

1. How big is the positive airway pressure devices market?

2. What is the future outlook of the positive airway pressure devices market?

3. What are the key factors driving the positive airway pressure devices market?

4. Which region accounts for the largest positive airway pressure devices market share?

5. Which are the leading companies in the global positive airway pressure devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Positive Airway Pressure Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Automatic Positive Airway Pressure (APAP) Devices
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Continuous Positive Airway Pressure (CPAP) Devices
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Bi-level Positive Airway Pressure (BiPAP) Devices
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by End User

  • 7.1 Hospitals and Sleep Labs
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Home Care
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 3B Medical Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
    • 13.3.2 Apex Medical Corp.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
    • 13.3.3 Compumedics Limited (D & DJ Burton Holdings Pty Ltd.)
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
    • 13.3.4 Drive Devilbiss Healthcare (Drive International LLC)
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
    • 13.3.5 Fisher & Paykel Healthcare Limited
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
    • 13.3.6 Koninklijke Philips N.V.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
      • 13.3.6.4 SWOT Analysis
    • 13.3.7 Resmed Inc.
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Smiths Group Plc
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Somnetics International Inc.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
    • 13.3.10 Vyaire Medical Inc.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio

List of Figures

  • Figure 1: Global: Positive Airway Pressure Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Positive Airway Pressure Devices Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Positive Airway Pressure Devices Market: Breakup by Product Type (in %), 2025
  • Figure 4: Global: Positive Airway Pressure Devices Market: Breakup by End User (in %), 2025
  • Figure 5: Global: Positive Airway Pressure Devices Market: Breakup by Region (in %), 2025
  • Figure 6: Global: Positive Airway Pressure Devices Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 7: Global: Positive Airway Pressure Devices (Automatic Positive Airway Pressure (APAP) Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 8: Global: Positive Airway Pressure Devices (Automatic Positive Airway Pressure (APAP) Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 9: Global: Positive Airway Pressure Devices (Continuous Positive Airway Pressure (CPAP) Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Positive Airway Pressure Devices (Continuous Positive Airway Pressure (CPAP) Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Positive Airway Pressure Devices (Bi-level Positive Airway Pressure (BiPAP) Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Positive Airway Pressure Devices (Bi-level Positive Airway Pressure (BiPAP) Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Positive Airway Pressure Devices (Hospitals and Sleep Labs) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Positive Airway Pressure Devices (Hospitals and Sleep Labs) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Positive Airway Pressure Devices (Home Care) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Positive Airway Pressure Devices (Home Care) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Positive Airway Pressure Devices (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Positive Airway Pressure Devices (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: North America: Positive Airway Pressure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: North America: Positive Airway Pressure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: United States: Positive Airway Pressure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: United States: Positive Airway Pressure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Canada: Positive Airway Pressure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Canada: Positive Airway Pressure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Asia Pacific: Positive Airway Pressure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Asia Pacific: Positive Airway Pressure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: China: Positive Airway Pressure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: China: Positive Airway Pressure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Japan: Positive Airway Pressure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Japan: Positive Airway Pressure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: India: Positive Airway Pressure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: India: Positive Airway Pressure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: South Korea: Positive Airway Pressure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: South Korea: Positive Airway Pressure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Australia: Positive Airway Pressure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Australia: Positive Airway Pressure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Indonesia: Positive Airway Pressure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Indonesia: Positive Airway Pressure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Others: Positive Airway Pressure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Others: Positive Airway Pressure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Europe: Positive Airway Pressure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Europe: Positive Airway Pressure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Germany: Positive Airway Pressure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Germany: Positive Airway Pressure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: France: Positive Airway Pressure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: France: Positive Airway Pressure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: United Kingdom: Positive Airway Pressure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: United Kingdom: Positive Airway Pressure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Italy: Positive Airway Pressure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Italy: Positive Airway Pressure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Spain: Positive Airway Pressure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Spain: Positive Airway Pressure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Russia: Positive Airway Pressure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Russia: Positive Airway Pressure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Others: Positive Airway Pressure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Others: Positive Airway Pressure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: Latin America: Positive Airway Pressure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: Latin America: Positive Airway Pressure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Brazil: Positive Airway Pressure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Brazil: Positive Airway Pressure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Mexico: Positive Airway Pressure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Mexico: Positive Airway Pressure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Others: Positive Airway Pressure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Others: Positive Airway Pressure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Middle East and Africa: Positive Airway Pressure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Middle East and Africa: Positive Airway Pressure Devices Market: Breakup by Country (in %), 2025
  • Figure 67: Middle East and Africa: Positive Airway Pressure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Global: Positive Airway Pressure Devices Industry: SWOT Analysis
  • Figure 69: Global: Positive Airway Pressure Devices Industry: Value Chain Analysis
  • Figure 70: Global: Positive Airway Pressure Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Positive Airway Pressure Devices Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Positive Airway Pressure Devices Market Forecast: Breakup by Product Type (in Million USD), 2026-2034
  • Table 3: Global: Positive Airway Pressure Devices Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 4: Global: Positive Airway Pressure Devices Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 5: Global: Positive Airway Pressure Devices Market: Competitive Structure
  • Table 6: Global: Positive Airway Pressure Devices Market: Key Players